Skip to main content

Table 5 Pooled analyses of the association between VDR rs731236 polymorphism and susceptibility to psoriasis

From: Pooling analysis regarding the impact of human vitamin D receptor variants on the odds of psoriasis

Models

M

I2

P heterogeneity

Stratification

case/control (N)

OR [95% CI]

P association

BH

allele C vs. T

R

47.5%

0.034

overall

1690/1857 (12)

0.91 [0.75~1.10]

0.325

0.690

57.2%

0.053

Asian

941/837 (5)

0.91 [0.58~1.43]

0.689

0.798

47.4%

0.090

Caucasian

699/970 (6)

0.87 [0.70~1.08]

0.216

0.629

47.7%

0.045

PB

1143/1436 (10)

0.90 [0.73~1.12]

0.341

0.524

49.7%

0.137

China

776/682 (3)

1.01 [0.62~1.64]

0.962

0.974

73.1%

0.024

Turkey

206/256 (3)

0.93 [0.54~1.61]

0.806

0.824

45.7%

0.056

PHWE > 0.05

1383/1675 (10)

0.90[0.72~1.11]

0.324

0.389

57.4%

0.021

PCR-RFLP

806/907 (8)

0.88 [0.68~1.14]

0.360

0.744

CC vs. TT

F

38.2%

0.114

overall

1325/1508 (9)

0.92[0.67~1.25]

0.581

0.690

0.0%

0.460

Asian

781/568 (3)

0.80[0.24~2.66]

0.717

0.798

58.7%

0.046

Caucasian

494/890 (5)

0.87 [0.62~1.22]

0.419

0.629

43.7%

0.087

PB

983/1167 (8)

0.90 [0.66~1.24]

0.524

0.524

73.8%

0.022

Turkey

206/256 (3)

1.05 [0.68~1.81]

0.868

0.974

0.0%

0.511

China

666/499 (2)

1.24 [0.28~5.53]

0.775

0.824

24.8%

0.231

PHWE > 0.05

1223/1406 (8)

0.79[0.56~1.12]

0.183

0.386

59.8%

0.029

PCR-RFLP

551/741 (6)

0.88 [0.61~1.28]

0.499

0.749

TC vs. TT

R

46.8%

0.043

overall

1485/1777 (11)

0.95[0.72~1.24]

0.690

0.690

51.5%

0.083

Asian

941/837 (5)

0.90[0.58~1.42]

0.658

0.798

61.0%

0.036

Caucasian

494/890 (5)

0.98[0.63~1.51]

0.918

0.918

46.6%

0.051

PB

1143/1436 (10)

0.91[0.68~1.22]

0.523

0.524

50.4%

0.133

China

776/682 (3)

0.97[0.58~1.63]

0.915

0.974

73.1%

0.024

Turkey

206/256 (3)

1.26 [0.53~2.99]

0.593

0.824

15.7%

0.299

PHWE > 0.05

1383/1675 (10)

0.85[0.69~1.06]

0.155

0.386

56.3%

0.033

PCR-RFLP

601/827 (7)

0.88 [0.61~1.28]

0.988

0.988

TC + CC vs. TT

R

50.7%

0.027

overall

1485/1777 (11)

0.94[0.71~1.23]

0.636

0.690

56.0%

0.059

Asian

941/837 (5)

0.90[0.57~1.44]

0.671

0.798

61.4%

0.035

Caucasian

494/890 (5)

0.93[0.62~1.40]

0.733

0.880

49.6%

0.037

PB

1143/1436 (10)

0.90 [0.67~1.19]

0.453

0.524

51.4%

0.128

China

776/682 (3)

0.99[0.59~1.66]

0.974

0.974

76.8%

0.013

Turkey

206/256 (3)

1.12 [0.47~2.68]

0.794

0.824

32.9%

0.145

PHWE > 0.05

1383/1675 (10)

0.86[0.67~1.09]

0.205

0.386

61.7%

0.016

PCR-RFLP

601/827 (7)

0.96 [0.63~1.45]

0.843

0.988

CC vs. TT + TC

F

4.4%

0.398

overall

1325/1508 (9)

0.91[0.69~1.20]

0.487

0.690

0.0%

0.506

Asian

781/568 (3)

0.85[0.26~2.85]

0.798

0.798

25.0%

0.254

Caucasian

494/890 (5)

0.86[0.64~1.16]

0.330

0.629

10.9%

0.345

PB

983/1167 (8)

0.90[0.68~1.19]

0.442

0.524

0.0%

0.543

China

666/499 (2)

1.30[0.29~5.76]

0.734

0.974

47.7%

0.148

Turkey

206/256 (3)

0.81 [0.52~1.27]

0.361

0.824

16.3%

0.301

PHWE > 0.05

1223/1406 (8)

0.89[0.64~1.23]

0.472

0.472

27.6%

0.228

PCR-RFLP

551/741 (6)

0.82 [0.59~1.14]

0.228

0.744

carrier C vs. T

F

1.1%

0.430

overall

1485/1777 (11)

0.93[0.80~1.09]

0.380

0.690

41.4%

0.145

Asian

941/837 (5)

0.92[0.68~1.23]

0.558

0.798

0.0%

0.617

Caucasian

494/890 (5)

0.92[0.76~1.11]

0.388

0.629

0.0%

0.492

PB

1143/1436 (10)

0.90[0.77~1.06]

0.223

0.524

37.9%

0.200

China

776/682 (3)

0.98[0.70~1.38]

0.922

0.974

16.6%

0.302

Turkey

206/256 (3)

0.96[0.70~1.32]

0.824

0.824

2.6%

0.415

PHWE > 0.05

1383/1675 (10)

0.91[0.77~1.07]

0.257

0.386

11.6%

0.341

PCR-RFLP

601/827 (7)

0.92 [0.75~1.11]

0.372

0.744

  1. M statistical model, R random effect, F fixed effect, PHWE P-value of Hardy-Weinberg equilibrium, Pheterogeneity P-value of Cochrane’s Q statistic for the assessment of heterogeneity, N Number of included case-control studies, OR odds ratio, CI confidence interval, Passociation P-value of association,
  2. BH Benjamini & Hochberg-adjusted Passociation